Riskpilot← Back to searchSign inGet full accessSCANBIO INGREDIENTS AS
ASActiveOrg 934997530Botngård, 7160 BjugnManufacture of oils and fats · NACE 1041Est. 198466 employees
Revenue 2024
NOK 963,2M
-17% vs 2023
EBITDA margin
-4.5%
-138% vs 2023
Equity ratio
36.8%
Financial strength
Net profit 2024
NOK 47,4M
-45% vs 2023
| Revenue | NOK 963,2M | -17% |
| EBITDA | NOK -43,1M | -138% |
| Net profit | NOK 47,4M | -45% |
| Total assets | NOK 932,6M | +34% |
| Equity | NOK 342,7M | -6% |
| Employees | 66 | — |
Legal name
SCANBIO INGREDIENTS AS
Org number
934997530
Legal form
Aksjeselskap
NACE code
1041 · Manufacture of oils and fats
Founded
2. januar 1984
Share capital
NOK 238 000 000
Employees
66 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Address
Botngård, 7160 Bjugn
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 142 566 | 138 959 | 180 809 | 0 | 184 263 | 243 885 | 227 363 | 218 938 | 233 705 | 286 931 | 497 386 | 510 310 | 531 974 | 624 338 | 751 440 | 1 161 275 | 963 204 |
| Staff expenses | −0 | −8 988 | −8 529 | −10 129 | −0 | −11 410 | −33 752 | −25 672 | −29 059 | −33 803 | −37 149 | −50 262 | −59 859 | −50 172 | −57 857 | −57 824 | −62 659 | −46 811 |
| EBITDA | 0 | 10 962 | 9 492 | 29 679 | 0 | 25 534 | −10 020 | −2 148 | −3 262 | 13 032 | 4 488 | 51 796 | 17 601 | 43 048 | 58 760 | 101 597 | 113 483 | −43 057 |
| Depreciation & amort. | −0 | −3 602 | −4 516 | −4 989 | −0 | −6 347 | −57 779 | −17 236 | −28 036 | −21 858 | −19 598 | −25 489 | −21 121 | −20 780 | −62 134 | −16 417 | −19 432 | −23 152 |
| EBIT | 0 | 7 360 | 4 976 | 24 689 | 0 | 19 188 | −67 799 | −19 384 | −31 298 | −8 826 | −15 110 | 26 307 | −3 520 | 22 268 | −3 373 | 85 180 | 94 051 | −66 208 |
| Net financials | 0 | −2 666 | 391 | −510 | 0 | −1 935 | −11 004 | −12 375 | −1 898 | −1 748 | −4 490 | −5 708 | −6 172 | −7 430 | −16 847 | 20 914 | 15 932 | 134 488 |
| Profit before tax | 0 | 4 695 | 5 367 | 24 180 | 0 | 17 253 | −78 803 | −31 759 | −33 196 | −10 574 | −19 600 | 20 599 | −9 692 | 14 838 | −20 220 | 106 094 | 109 983 | 68 279 |
| Tax | −0 | 1 316 | 1 503 | 6 773 | −0 | 7 612 | −22 011 | −8 539 | −7 524 | −2 860 | 219 | 5 299 | −2 145 | 3 229 | −5 225 | 23 341 | 24 197 | 20 862 |
| Net profit | 0 | 3 379 | 3 864 | 17 407 | 0 | 9 641 | −56 792 | −23 221 | −25 672 | −7 715 | −19 820 | 15 300 | −7 546 | 11 609 | −14 995 | 82 753 | 85 787 | 47 417 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 142 556 | 179 104 | 173 203 | — | 252 802 | 235 245 | 295 340 | 250 704 | 325 069 | 296 422 | 335 034 | 361 974 | 369 588 | 354 557 | 537 612 | 695 795 | 932 556 |
| Equity | — | 29 837 | 32 616 | 38 225 | — | 34 462 | 13 714 | −8 791 | 198 404 | 190 811 | 167 432 | 195 658 | 189 276 | 203 444 | 196 838 | 351 772 | 365 362 | 342 730 |
| Long-term debt | 0 | 29 557 | 33 994 | 34 063 | 0 | 176 222 | 176 007 | 208 329 | 5 359 | 8 696 | 2 743 | 1 405 | 0 | 0 | 0 | 696 | 4 529 | 5 634 |
| Short-term debt | 0 | 83 162 | 112 493 | 100 915 | 0 | 42 119 | 45 322 | 95 556 | 46 695 | 125 021 | 125 991 | 136 311 | 170 846 | 164 932 | 157 719 | 185 144 | 325 904 | 584 192 |
| Total debt | 0 | 112 719 | 146 488 | 134 978 | 0 | 218 340 | 221 329 | 303 886 | 52 054 | 133 717 | 128 734 | 137 716 | 170 846 | 164 932 | 157 719 | 185 839 | 330 433 | 589 826 |
EBITDA margin
-4.5%
This company
15.8%
Market median
-128% vs market
20072024
Equity ratio
36.8%
This company
38.2%
Market median
+4% vs market
20072024
Return on equity
13.8%
This company
18.4%
Market median
+25% vs market
20072024
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20072024
Asset turnover
1.03×
This company
1.12×
Market median
+8% vs market
20072024
Debt / equity
1.72×
This company
0.62×
Market median
-177% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Scanbio Marine Group As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Scanbio Marine Group Topco AsScanbio Marine Group Holding AsScanbio Marine Group As
SCANBIO INGREDIENTS AS (this company)Board members of SCANBIO INGREDIENTS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Are Dybvad Denstad | Board of Directors | 0 companies |
| Tor Vikenes | Chairman | 0 companies |
| Espen Müller | Board of Directors | 0 companies |
| Gabriel Kamal El Khaloui | Chairman | 0 companies |